Key result
A fixed-dose combination of bisoprolol and amlodipine was evaluated for its effects on patient adherence and blood pressure control in over 10,000 hypertensive patients.
Why the study?
Does a fixed-dose combination of bisoprolol and amlodipine improve patient adherence and blood pressure control in hypertensive patients with and without type 2 diabetes mellitus or coronary artery disease?
Does a fixed-dose combination of bisoprolol and amlodipine improve patient adherence and blood pressure control in hypertensive patients with and without type 2 diabetes mellitus or coronary artery disease?
A non-interventional study investigated the effect of a fixed-dose combination of bisoprolol and amlodipine on adherence and blood pressure control in hypertensive patients.
Hypothesis-generating for fixed-dose bisoprolol-amlodipine in hypertension; should not yet change practice.
The data from a non-interventional study in more than 10,000 patients were assessed to analyse relationships between hypertension and diabetes or cardiovascular diseases. A further aim was to investigate the effect exerted by treatment with a fixed-dose combination (FDC) of bisoprolol and amlodipine in respect of patient adherence and blood pressure control.
No takes yet. Share an insight, caveat, or question.
A 2015 study studied this question. A fixed-dose combination of bisoprolol and amlodipine was evaluated for its effects on patient adherence and blood pressure control in over 10,000 hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: